In HNSCC, the angiogenetic activity of VEGF seems to interact directly with the innate and adaptive pathways of immune response, inhibiting the NF-kB cascade, which in turn regulates the expression of PD-L1, thus affecting the function of the immune checkpoint [165,166]. The gene discussed is VEGFA; the disease is head and neck squamous cell carcinoma.